Freeline Therapeutics Holdings plc American Depositary Shares
FRLN
FRLN was delisted on the 16th of February, 2024.
14 hedge funds and large institutions have $26.4M invested in Freeline Therapeutics Holdings plc American Depositary Shares in 2022 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 5 reducing their positions, and 4 closing their positions.
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
18% less funds holding
Funds holding: 17 → 14 (-3)
21% less capital invested
Capital invested by funds: $33.2M → $26.4M (-$6.84M)
60% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 5
75% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 4
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TAM
TFG Asset Management
Grand Cayman,
Cayman Islands
|
+$208K |
| 2 |
TSS
Two Sigma Securities
New York
|
+$10.3K |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$10.1K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VFA
Values First Advisors
Gray,
Tennessee
|
-$49K |
| 2 |
SG Americas Securities
New York
|
-$45K |
| 3 |
Renaissance Technologies
New York
|
-$44.4K |
| 4 |
CA
CHI Advisors
New York
|
-$41.6K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$31K |
FRLN Hedge Fund Activity: Q3 2022 in Review
14 of the 5,806 institutional investors tracked by Wall St. Rank reported a position in Freeline Therapeutics Holdings plc American Depositary Shares (FRLN) for Q3 2022, worth a combined $26.4M — down 21% from $33.2M a quarter earlier.
Sellers outnumbered buyers: 4 funds closed out of FRLN and 1 opened new positions — a net loss of 3 holders — while 5 trimmed existing stakes and 2 added.
The largest buyer was TFG Asset Management, adding an estimated $208K. The largest seller was Values First Advisors, exiting entirely with an estimated $49K sold.
- 14 institutional investors held Freeline Therapeutics Holdings plc American Depositary Shares (FRLN) as of Q3 2022, down from 17 in Q2 2022.
- Funds reported $26.4M of Freeline Therapeutics Holdings plc American Depositary Shares stock for Q3 2022, down 21% quarter-over-quarter.
- 1 fund opened new Freeline Therapeutics Holdings plc American Depositary Shares positions in Q3 2022 and 4 closed out, a net change of -3 holders.
- The largest Freeline Therapeutics Holdings plc American Depositary Shares buyer in Q3 2022 was TFG Asset Management, an estimated $208K added.
- The largest Freeline Therapeutics Holdings plc American Depositary Shares seller in Q3 2022 was Values First Advisors, an estimated $49K sold.
Based on aggregated 13F filings for Q3 2022.